Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

被引：0
|
作者：
Dana J. Holger
Nicholas S. Rebold
Sara Alosaimy
Taylor Morrisette
Abdalhamid Lagnf
Ana Christine Belza
Ashlan J. Kunz Coyne
Amer El Ghali
Michael P. Veve
Michael J. Rybak
机构：
[1] Wayne State University,Anti
[2] Wayne State University,Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences
[3] Henry Ford Hospital,Department of Pharmacy
[4] Detroit Receiving Hospital,Department of Pharmacy Services
[5] Detroit Medical Center,School of Medicine
[6] Wayne State University,Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy
[7] Seres Therapeutics,Department of Pharmacy Services
[8] Medical University of South Carolina,undefined
[9] Medical University of South Carolina Shawn Jenkins Children’s Hospital,undefined
来源：
Infectious Diseases and Therapy | 2022年 / 11卷
关键词：
Ceftolozane–tazobactam; HABP/VABP; Multidrug resistance; Pneumonia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1965 / 1980
页数：15
相关论文
共 50 条
  • [31] Use of Continuous-Infusion Ceftolozane/Tazobactam in a Multidrug-Resistant Pseudomonas aeruginosa Urinary Tract Infection in the Outpatient Setting
    Jones, Bruce M.
    Smith, Bradley
    Bland, Christopher M.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (08) : 715 - 716
  • [32] Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis
    Kwon, Yong Soo
    Kim, Yee Hyung
    Suh, Gee Young
    Chung, Man Pyo
    Kim, Hojoong
    Kwon, O. Jung
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Shim, Young Mog
    Koh, Won-Jung
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (04) : 496 - 502
  • [33] Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections
    Samonis, G.
    Vardakas, K. Z.
    Kofteridis, D. P.
    Dimopoulou, D.
    Andrianaki, A. M.
    Chatzinikolaou, I.
    Katsanevaki, E.
    Maraki, S.
    Falagas, M. E.
    INFECTION, 2014, 42 (04) : 721 - 728
  • [34] Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections
    G. Samonis
    K. Z. Vardakas
    D. P. Kofteridis
    D. Dimopoulou
    A. M. Andrianaki
    I. Chatzinikolaou
    E. Katsanevaki
    S. Maraki
    M. E. Falagas
    Infection, 2014, 42 : 721 - 728
  • [35] Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors
    Trinh, Trang D.
    Zasowski, Evan J.
    Claeys, Kimberly C.
    Lagnf, Abdalhamid M.
    Kidambi, Shravya
    Davis, Susan L.
    Rybak, Michael J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 89 (01) : 61 - 66
  • [36] The Prevalence of Multidrug-Resistant and Extensively Drug-Resistant Infections in Respiratory Intensive Care Unit, Causative Microorganisms and Mortality
    Uluc, Kamuran
    Ozcelik, Hatice Kutbay
    Ongel, Esra Akkutuk
    Cenger, Derya Hircin
    Colakoglu, Sukran Merve
    Ilkaya, Nazan Koylu
    Devran, Ozkan
    Sezen, Aysegul Inci
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 4913 - 4919
  • [37] Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model
    Montero, Maria M.
    Domene-Ochoa, Sandra
    Lopez-Causape, Carla
    Luque, Sonia
    Sorli, Luisa
    Campillo, Nuria
    Padilla, Eduardo
    Prim, Nuria
    Ferrer-Alapont, Lorena
    Angulo-Brunet, Ariadna
    Grau, Santiago
    Oliver, Antonio
    Horcajada, Juan P.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model
    María M. Montero
    Sandra Domene-Ochoa
    Carla López-Causapé
    Sonia Luque
    Luisa Sorlí
    Núria Campillo
    Eduardo Padilla
    Núria Prim
    Lorena Ferrer-Alapont
    Ariadna Angulo-Brunet
    Santiago Grau
    Antonio Oliver
    Juan P. Horcajada
    Scientific Reports, 11
  • [39] Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa Meningitis
    McCreary, Erin K.
    Byers, Karin E.
    Fernandes, Carolyn
    Kline, Ellen G.
    Nicolau, David P.
    Shields, Ryan K.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (12):
  • [40] Prevalence of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a tertiary level Intensive Care Unit
    Gill, J. S.
    Arora, Sunil
    Khanna, S. P.
    Kumar, K. V. S. Hari
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2016, 8 (04) : 155 - 159
12345